Literature DB >> 3592803

The fundamental hemodynamic mechanism underlying gastric "stress ulceration" in cardiogenic shock.

R W Bailey, G B Bulkley, S R Hamilton, J B Morris, U H Haglund, J E Meilahn.   

Abstract

Acute hemorrhagic ulceration of the gastric mucosa is seen frequently in patients with hypovolemic or cardiogenic shock. Although such lesions clearly are related to regional gastric ischemia, little attention has been directed at the underlying mechanism(s) mediating the ischemia itself. To this end, anesthetized pigs were subjected to sustained cardiogenic shock (mild hemorrhage and pericardial tamponade) such that cardiac output was reduced to 38 +/- 1% of the baseline level for 4 hours, followed by release of the tamponade, reinfusion of the shed blood, and resuscitation for 2 hours. During the period of shock, there was profound regional gastric ischemia, resulting from severe and disproportionate gastric vasoconstriction. "Blinded" gross and microscopic evaluation of the stomachs removed after the experiment revealed severe mucosal ischemic necrosis, hemorrhage, and ulceration, whereas sham-operated pigs showed no lesions. The characteristics of this model therefore mimic the essential features of the gastric "stress ulceration" syndrome. Prior confirmed total alpha-adrenergic blockade with phenoxybenzamine failed to alter these features significantly. In contrast, prior ablation of the renin-angiotensin axis, whether by angiotensin-converting enzyme inhibition with teprotide or by bilateral nephrectomy, significantly and substantially ameliorated the ischemia, vasospasm, and mucosal injury. In this model of cardiogenic shock, acute gastric mucosal "stress ulceration" is caused by a disproportionately severe regional gastric ischemia resulting from selective splanchnic vasospasm that is unaffected by sympathetic blockade but abolished by prior ablation of the renin-angiotensin axis. Like nonocclusive small bowel ischemia, ischemic colitis, and the "shock liver" syndrome, gastric "stress ulceration" is yet another component of the multiple splanchnic organ failure syndrome that appears to be mediated primarily by the remarkable sensitivity of the splanchnic vascular bed to the renin-angiotensin axis.

Entities:  

Mesh:

Year:  1987        PMID: 3592803      PMCID: PMC1493091          DOI: 10.1097/00000658-198706000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  41 in total

1.  Protection of the small intestine from nonocclusive mesenteric ischemic injury due to cardiogenic shock.

Authors:  R W Bailey; G B Bulkley; S R Hamilton; J B Morris; U H Haglund
Journal:  Am J Surg       Date:  1987-01       Impact factor: 2.565

2.  Intestinal vasoconstriction after hemorrhage: roles of vasopressin and angiotensin.

Authors:  J R McNeill; R D Stark; C V Greenway
Journal:  Am J Physiol       Date:  1970-11

3.  Regional differences in vascular tachyphylaxis to angiotensin in the cat.

Authors:  O Jonsson; J Svanvik; P Vikgren
Journal:  Angiologica       Date:  1967

4.  Angiotensin tachyphylaxis and its reversal.

Authors:  P A Khairallah; I H Page; F M Bumpus; R K Türker
Journal:  Circ Res       Date:  1966-08       Impact factor: 17.367

5.  A swine stress ulcer model.

Authors:  L Norton; P Nolan; J E Sales; B Eiseman
Journal:  Ann Surg       Date:  1972-08       Impact factor: 12.969

6.  Experimental nonocclusive mesenteric ischemia. Physiologic and anatomic observations.

Authors:  L F Williams; L F Anastasia; C A Hasiotis; M A Bosniak; J J Byrne
Journal:  Arch Surg       Date:  1968-06

7.  Factors other than major vascular occlusion that contribute to intestinal infarction.

Authors:  P H Jordan; D Boulafendis; G A Guinn
Journal:  Ann Surg       Date:  1970-02       Impact factor: 12.969

8.  Gastric microcirculatory changes in hemorrhagic shock.

Authors:  G Bulkley; H Goldman; L Trencis; W Silen
Journal:  Surg Forum       Date:  1970

9.  Natural history and surgical dilemma of "stress" gastric bleeding.

Authors:  C E Lucas; C Sugawa; J Riddle; F Rector; B Rosenberg; A J Walt
Journal:  Arch Surg       Date:  1971-04

10.  Pathogenesis of nonocclusive ischemic colitis.

Authors:  R W Bailey; G B Bulkley; S R Hamilton; J B Morris; G W Smith
Journal:  Ann Surg       Date:  1986-06       Impact factor: 12.969

View more
  8 in total

1.  [Reactive acalculous cholecystitis: a bland and asymptomatic course--incidence of a classical stress disease].

Authors:  K Meissner; G Meiser; E Schwaiger
Journal:  Langenbecks Arch Chir       Date:  1989

2.  Stress ulcer prophylaxis and gastric alkalinization--death of a myth?

Authors:  M Tryba
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 3.  Stress-related mucosal disease in the critically ill patient.

Authors:  Marc Bardou; Jean-Pierre Quenot; Alan Barkun
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-06       Impact factor: 46.802

4.  Effect of prolonged selective intramesenteric arterial vasodilator therapy on intestinal viability after acute segmental mesenteric vascular occlusion.

Authors:  J E Meilahn; J B Morris; E P Ceppa; G B Bulkley
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

5.  Changes in regional blood flow and pCO(2) gradients during isolated abdominal aortic blood flow reduction.

Authors:  Rafael Knuesel; Stephan M Jakob; Lukas Brander; Hendrik Bracht; Andreas Siegenthaler; Jukka Takala
Journal:  Intensive Care Med       Date:  2003-09-17       Impact factor: 17.440

6.  Effects of an angiotensin II antagonist on organ perfusion during the post-resuscitation phase in pigs.

Authors: 
Journal:  Crit Care       Date:  1998       Impact factor: 9.097

7.  Lymphocytic Myocarditis.

Authors:  Lily Mahler; Brandi McCleskey
Journal:  Am J Forensic Med Pathol       Date:  2021-11-05       Impact factor: 1.108

Review 8.  Heart Failure and Pancreas Exocrine Insufficiency: Pathophysiological Mechanisms and Clinical Point of View.

Authors:  Olivier C Dams; Marlene A T Vijver; Charlotte L van Veldhuisen; Robert C Verdonk; Marc G Besselink; Dirk J van Veldhuisen
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.